Cumulative incidence of permanent stoma after sphincter preserving low anterior resection of mid and low rectal cancer

Dis Colon Rectum. 2013 Oct;56(10):1134-42. doi: 10.1097/DCR.0b013e31829ef472.

Abstract

Background: Changes in the treatment of rectal cancer during the past decades have led to an increase in sphincter preservation with a consecutive decline in abdominoperineal resection rates.

Objective: The aim of this study was to analyze the cumulative incidence of permanent stoma in patients undergoing sphincter-preserving resection of mid and low rectal cancer.

Design: This study is a retrospective analysis of prospectively collected data.

Settings: This study was conducted at a tertiary referral cancer hospital.

Patients: From 2003 to 2010, 125 patients with primary mid and low rectal cancer who underwent sphincter-preserving low anterior resection were included.

Main outcome measures: The occurrence of a permanent stoma over time was investigated by using a Cox proportional hazards regression model and competing-risk models, with death as a competing risk. The risk factors were assessed by computing HRs and a Cox proportional hazards regression.

Results: After a median follow-up time of 61 months (range, 22-113), 15 of 125 patients ended up with a permanent stoma, accounting for a 5-year cumulative incidence of 6% (95% CI, 4%-11%). The reasons for obtaining a permanent stoma were anastomotic leakage (60%, 9/15), intractable fecal incontinence (27%, 4/15), and local recurrence (13%, 2/15). The Cox proportional hazards regression identified anastomotic leakage (HR, 6.10; 95% CI, 2.23-16.71; p = 0.0004) and coloanal anastomosis (HR, 4.31; 95% CI, 1.49-12.47; p = 0.007) as statistically significant risk factors.

Limitations: Because of the small number of events in this sample, further investigations with a larger number of patients are required. Fecal incontinence was assessed by patient self-reported data without the use of a validated score.

Conclusion: The 5-year cumulative incidence of a permanent stoma was 6%. Anastomotic leakage and coloanal anastomosis were identified as risk factors. These details should be considered before sphincter-preserving surgery.

MeSH terms

  • Adenocarcinoma / pathology
  • Adenocarcinoma / therapy*
  • Adult
  • Aged
  • Aged, 80 and over
  • Anal Canal / surgery*
  • Anastomosis, Surgical / adverse effects
  • Anastomotic Leak / surgery
  • Antineoplastic Agents / therapeutic use
  • Chemoradiotherapy, Adjuvant
  • Colon / surgery*
  • Colostomy*
  • Fecal Incontinence / surgery
  • Female
  • Fluorouracil / therapeutic use
  • Humans
  • Ileostomy
  • Male
  • Middle Aged
  • Neoadjuvant Therapy
  • Neoplasm Recurrence, Local / surgery*
  • Organ Sparing Treatments
  • Rectal Neoplasms / pathology
  • Rectal Neoplasms / therapy*
  • Risk Factors
  • Time Factors

Substances

  • Antineoplastic Agents
  • Fluorouracil